Proov Announces 4th Patent to identify the Fertile Window— Proov, a diagnostics company providing medical-grade tests at-home and a support platform, is announcing today that it has received patent issue notification for its fourth utility patent. It is a the progesterone (or PdG) testing via urine test, a method for identifying the fertile window using tests for PdG and other hormones, and an all-hormone test that involves testing for PdG and one or more other hormones related to menstrual cycles.
Progesterone is a vital hormone produced by the ovary after the ovulation. One of the main functions of progesterone is to prepare the uterine lining to allow for implantation. Without enough progesterone after the ovulation period, it could make it more difficult for implantation properly take place.
Prior to the Proov’s offering – the only FDA-Cleared urine PdG test – there was no diagnostic test could prove successful Ovulation. Successful ovulation is defined as continuous elevated PdG levels during the implantation period and gives the highest chances of getting pregnant. Proov’s fourth patent adds to Proov’s leading patent portfolio, related to the testing of PdG in urine in women. This patent provides the use of a home-based test that can identify both PdG and the luteinizing hormone (LH) as well as providing users with security when they display the results of PdG and LH tests on an external device that has an interactive user interface. The new patent encompasses an instrument that measures follicle stimulating hormones (FSH) and estrogen, LH, and progesterone markers in urine to identify the fertile window of women. Proov continues to be the leader in the development of hormone testing at-home to empower women, and has a variety of related technologies that are covered in pending patent applications.
Previous Reporting The best tool to know your fertility window. In brief The best way to find out your fertile period.
“As Proov continues to expand one of the most important patent portfolios in hormone signaling for women’s health, we will continue to build upon our efforts to aggressively enforce our patents and deter others from infringing upon the PdG and other testing technology that Proov has created,” Dr. Amy Beckley, Proov’s co-founder. Amy Beckley.
Proov Tests can be found on Amazon as well as proovtest.comand are utilized by physicians across the United States. They are non-invasive and cleared for use at home, making fertility diagnostics more accessible to patients.